Alverbratt, C. et al. 2025. Radium-223 use and survival by line of treatment in metastatic castration-resistant prostate cancer: a nationwide population-based register study. Acta Oncologica. 64, (Oct. 2025), 1391–1403. DOI:https://doi.org/10.2340/1651-226X.2025.43794.